obesity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male and premenopausal female participants aged 18-45 years old are eligible to sign the informed consent form. 2. Participants diagnosed as obese based on a body mass index (BMI) ranging from 28 to 40 kg/m2.
Exclusion criteria
Exclusion criteria: 1. Diagnosis of type 1 or type 2 diabetes, gestational diabetes, and some specific types of diabetes 2. Taking medications affecting weight or energy intake/energy expenditure in the last 3 months, including weight loss medications, antipsychotic drugs and glucocorticoids. 3. Underwent weight-loss surgery in the last 6 months 4. Currently participating in weight loss programs or weight change in the past 3 months (> 5% current body weight) 5. Serious liver dysfunction or chronic kidney disease (AST or ALT > 3 times the upper limit of normal, or eGFR6.0 as measured at screening) 12. Patients who took antibiotics or probiotics in the past 1 months 13. Patients who abused drugs or alcohol or suffered from severe mental disorder (major depression, schizophrenia, bipolar disorder) 14.Patients who are unwilling or unable to give informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| weight; | — |
Secondary
| Measure | Time frame |
|---|---|
| Gastrointestinal flora;Biochemical test; | — |
Countries
China
Contacts
the Tenth People's Hospital of Tongji University